| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide an agent for prolonging effective treatment of Parkinson's disease by delaying or removing the need for L-DOPA therapy. <P>SOLUTION: The agent and the like for prolonging effective treatment of Parkinson's disease by delaying or removing the patient's need for add-on L-DOPA therapy comprise either, for example, (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a combination of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine and a dopamine agonist. <P>COPYRIGHT: (C)2012,JPO&INPIT |
